IPO action brief: YLUZ files, no retail window yet
YPF Luz has filed for a proposed NYSE listing, but no price, deadline, or verified mainstream retail allocation is available yet; the brief separates watch-only names from actionable IPO access.
Today's spotlight
YPF Energia Electrica, the Argentine power-generation business spun out of state-owned energy company YPF, filed a preliminary F-1 for a proposed NYSE listing under YLUZ. The international offering would be sold as American Depositary Shares, with each ADS representing 10 Class B common shares. The company itself is not selling shares and would receive no IPO proceeds. 1
Why retail investors may care: this is a sizable, cross-border power asset rather than a pre-revenue concept. YPF Luz says it operates 17 plants with 3,764 MW of installed capacity, including 2,740 MW of thermal and 1,024 MW of renewable capacity. It supplied 15.0 TWh in the 12 months ended March 31, 2026, equal to 9.9% of electricity supplied on Argentina's SADI grid. Renaissance Capital estimates the eventual US deal could raise about $300 million, but the filing does not set the amount. 2
The important number is the 3,764 MW footprint. The trade-off is that the business is tied to Argentina's power prices, regulation, currency controls, customer collections, and fuel costs. The filing also says YPF is expected to retain more than 50% of voting power, leaving YLUZ as a controlled company with reduced exposure to some NYSE governance requirements. 3
| Item | Verified status |
|---|---|
| Proposed listing | YLUZ on the NYSE; concurrent BYMA listing is planned. 1 |
| Price range | Not disclosed in the preliminary filing. |
| Minimum buy-in | Not available until offer terms and broker access are published. |
| Subscription / timing | Registration statement is preliminary and not yet effective; no public pricing or listing date is set. |
| Broker access | No public allocation window was verified for Robinhood, Fidelity, Schwab, E*TRADE, or Webull. |
Bottom line: YLUZ is a real operating-company filing to watch, but it is not an actionable retail IPO today. There is no price, deadline, minimum order, or verified mainstream broker route yet.
Actionable now
No open US IPO allocation could be verified in the public sources reviewed for July 15. The calendar shows companies at pricing or expected-trading stages, which is different from a broker allocation window. 4
| Ticker | Price range | Minimum buy-in | Deadline | Available mainstream brokers |
|---|---|---|---|---|
| None verified | Not disclosed | Not available | None verified | No public access confirmed |
If a broker shows an IPO order ticket, confirm that it is an actual allocation program and check the prospectus before treating it as access. Calendar presence alone is not proof of availability.
Market pulse
- Csquare is expected to trade July 16 with 50.0 million shares marketed at $23.00-$27.00 and an estimated $1.25 billion deal at the midpoint. That is the largest visible US IPO on the near-term calendar, but no public oversubscription or retail-allocation figure was verified. 4
- Standard Nuclear is also expected to trade July 16, offering 18.3 million shares at $18.00-$21.00 for an estimated $355.9 million deal. Its profile lists $3.36 million of last-12-month revenue and a $14.97 million net loss, so the nuclear theme comes with early-stage operating risk. 5
- Tarsier Pharma is expected to trade July 15 at an $8.00-$10.00 range for an estimated $45 million deal. The Phase 3 eye-drug developer lists no last-12-month revenue and a $5.07 million net loss. Treat the first-day move as a trading signal, not proof that the underlying clinical risk has changed. 6
HK desk
No Hong Kong public subscription was verified for action today. Phillip Securities' public IPO information page says, "There is no scheduled IPO at this moment," so there is no confirmed offer price, board lot, deadline, or international-broker route to put in an action table. 7
On the radar
The following names are the next two-week calendar watch, not confirmed retail allocations. Where the public calendar gives only a week, the exact pricing date remains unreported.
| Name | Symbol | Pricing date | Expected listing | Why watch |
|---|---|---|---|---|
| Csquare | CSQR | Not published in the accessible calendar | July 16 | $1.25 billion estimated deal; data-center infrastructure with $1.02 billion of last-12-month revenue and a $150.94 million net loss. 8 |
| Standard Nuclear | STDN | Not published in the accessible calendar | July 16 | Advanced nuclear fuel exposure and a $355.9 million estimated deal. 5 |
| MetaOptics | MOT | Not set | Week of July 20 | Small uplisting with a $5.00-$7.00 indicated range and an estimated $18 million deal. 4 |
| Ticketplus | TP | Not set | Week of July 20 | Consumer ticketing name with a $13.00-$15.00 indicated range and an estimated $25 million deal. 4 |
| Web3Labs Global | MDAT | Not set | Week of July 27 | Hong Kong-based digital-asset infrastructure name on the US calendar, with an indicated $4.00-$5.00 range. 4 |
Watch the next filing update for YLUZ. Until it supplies a price range and an effective registration statement, the correct status is watch-only. This brief is market information, not investment advice.
References
- 1
- 2YPF Energia Electrica files for an estimated $300 million US-Argentina dual listing
renaissancecapital.com
- 3
- 4IPOScoop IPO calendar
iposcoop.com
- 5Standard Nuclear IPO profile
iposcoop.com
- 6Tarsier Pharma IPO profile
iposcoop.com
- 7Phillip Securities IPO Information
poems.com.hk
- 8Csquare IPO profile
iposcoop.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.